CliffBio
small molecule

ARISTADA INITIO KIT

ARIPIPRAZOLE LAUROXIL

Loss of exclusivityApril 2039latest FDA-listed patent expiry
CompanyALKERMES INC

Drug detail

Brand nameARISTADA INITIO KIT
Active ingredientARIPIPRAZOLE LAUROXIL
Strength675MG/2.4ML (281.25MG/ML)
Dosage formSUSPENSION, EXTENDED RELEASE
RouteINTRAMUSCULAR
ModalitySmall molecule
FDA approvalJune 2018
Marketing statusRX

Listed patents

PatentExpiresType
12251381April 2039use U-543
11273158April 2039use U-543
10016415September 2035product
10849894August 2035use U-543
11154552August 2035product
10688091August 2035product
8431576October 2030substance
10112903June 2030substance
8796276June 2030use U-543

More from ALKERMES INC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.